J 2016

Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance

MEBAZAA, A., H. TOLPPANEN, C. MUELLER, J. LASSUS, S. DISOMMA et. al.

Základní údaje

Originální název

Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance

Autoři

MEBAZAA, A. (250 Francie), H. TOLPPANEN (246 Finsko), C. MUELLER (756 Švýcarsko), J. LASSUS (246 Finsko), S. DISOMMA (380 Itálie), G. BAKSYTE (440 Litva), M. CECCONI (826 Velká Británie a Severní Irsko), D.J. CHOI (410 Korejská republika), A.C. SOLAL (250 Francie), M. CHRIST (276 Německo), J. MASIP (724 Španělsko), M. ARRIGO (250 Francie), S. NOUIRA (788 Tunisko), D. OJJI (566 Nigérie), F. PEACOCK (840 Spojené státy), M. RICHARDS (554 Nový Zéland), N. SATO (392 Japonsko), K. SLIWA (710 Jižní Afrika), Jindřich ŠPINAR (203 Česká republika, garant, domácí), H. THIELE (276 Německo), M.B. YILMAZ (792 Turecko) a J. JANUZZI (840 Spojené státy)

Vydání

Intensive care medicine, NEW YORK, SPRINGER, 2016, 0342-4642

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 12.015

Kód RIV

RIV/00216224:14110/16:00090652

Organizační jednotka

Lékařská fakulta

UT WoS

000368722000002

Klíčová slova anglicky

Heart failure; Cardiogenic shock; Emergency; Treatment

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 29. 8. 2016 16:51, Soňa Böhmová

Anotace

V originále

Purpose: Acute heart failure (AHF) causes high burden of mortality, morbidity, and repeated hospitalizations worldwide. This guidance paper describes the tailored treatment approaches of different clinical scenarios of AHF and CS, focusing on the needs of professionals working in intensive care settings. Results: Tissue congestion and hypoperfusion are the two leading mechanisms of end-organ injury and dysfunction, which are associated with worse outcome in AHF. Diagnosis of AHF is based on clinical assessment, measurement of natriuretic peptides, and imaging modalities. Simultaneously, emphasis should be given in rapidly identifying the underlying trigger of AHF and assessing severity of AHF, as well as in recognizing end-organ injuries. Early initiation of effective treatment is associated with superior outcomes. Oxygen, diuretics, and vasodilators are the key therapies for the initial treatment of AHF. In case of respiratory distress, non-invasive ventilation with pressure support should be promptly started. In patients with severe forms of AHF with cardiogenic shock (CS), inotropes are recommended to achieve hemodynamic stability and restore tissue perfusion. In refractory CS, when hemodynamic stabilization is not achieved, the use of mechanical support with assist devices should be considered early, before the development of irreversible end-organ injuries. Conclusion: A multidisciplinary approach along the entire patient journey from pre-hospital care to hospital discharge is needed to ensure early recognition, risk stratification, and the benefit of available therapies. Medical management should be planned according to the underlying mechanisms of various clinical scenarios of AHF.